Cell-derived microparticles and exosomes in neuroinflammatory disorders

被引:49
作者
Horstman, Lawrence L. [1 ]
Jy, Wenche
Minagar, Alireza
Bidot, Carlos J.
Jimenez, Joaquin J.
Alexander, J. Steven
Ahn, Yeon S.
机构
[1] Univ Miami, Dept Med, Wallace H Coulter Platelet Lab, Miami, FL 33136 USA
[2] Louisiana State Univ, Hlth Sci Ctr, Dept Neurol, Shreveport, LA 71103 USA
[3] Louisiana State Univ, Hlth Sci Ctr, Dept Cellular & Mol Physiol, Shreveport, LA 71103 USA
来源
NEUROBIOLOGY OF MULTIPLE SCLEROSIS | 2007年 / 79卷
关键词
D O I
10.1016/S0074-7742(07)79010-4
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
All blood cells and the vascular endothelium shed microparticles (MP) from their plasma membranes when suitably stimulated, and assay of MP in patient blood has found increasing application to the monitoring of disease states. In addition, mounting evidence suggests that MP are not mere epiphenomena but play significant roles in the pathophysiology of thromboses, inflammation, and cancers. This chapter endeavors to summarize the limited number of studies thus far done on MP in neurological disorders such as multiple sclerosis (MS), transient ischemic attacks, and the neurological manifestations of antiphospholipid syndrome (APS). In addition, the chapter offers some plausible hypotheses on possible roles of MP in the pathophsyiology of these disorders, chiefly, the hypothesis that MP are indeed important participants in some neuropathologies, especially those which are ischemic in nature, but probably also inflammatory ones. The chapter also goes over the history and general principles of MP studies (e.g., assay methods and pitfalls), comparison with alternative methods (e.g., soluble markers of disease states), subclasses of MP (such as exosomes), and other topics aimed at helping readers to consider MP studies in their own clinical fields. Tables include a listing of bioactive agents known to be carried on MP, many of which were heretofore considered strictly soluble, and some of which can be transferred from cell to cell via MP vectors, for example certain cytokine receptors.
引用
收藏
页码:227 / 268
页数:42
相关论文
共 295 条
  • [1] ABRAMS C, 1991, THROMB HAEMOSTASIS, V65, P467
  • [2] ABRAMS CS, 1990, BLOOD, V75, P128
  • [3] Neurocognitive impairment and driving performance after coronary artery bypass surgery
    Ahlgren, E
    Lundqvist, A
    Nordlund, A
    Aren, C
    Rutberg, H
    [J]. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2003, 23 (03) : 334 - 340
  • [4] Differences of soluble CD40L in sera and plasma: Implications on CD40L assay as a marker of thrombotic risk
    Ahn, ER
    Lander, G
    Jy, W
    Bidot, CJ
    Jimenez, JJ
    Horstman, LL
    Ahn, YS
    [J]. THROMBOSIS RESEARCH, 2004, 114 (02) : 143 - 148
  • [5] More on: Cellular microparticles: what are they bad or good for?
    Ahn, YS
    Jy, W
    Jimenez, JJ
    Horstman, LL
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2004, 2 (07) : 1215 - 1216
  • [6] Vascular dementia in patients with immune thrombocytopenic purpura
    Ahn, YS
    Horstman, LL
    Jy, W
    Jimenez, JJ
    Bowen, B
    [J]. THROMBOSIS RESEARCH, 2002, 107 (06) : 337 - 344
  • [7] Human bone marrow megakaryocytes and platelets express PPARγ, and PPARγ agonists blunt platelet release of CD40 ligand and thromboxanes
    Akbiyik, F
    Ray, DM
    Gettings, KF
    Blumberg, N
    Francis, CW
    Phipps, RP
    [J]. BLOOD, 2004, 104 (05) : 1361 - 1368
  • [8] Albanese J, 1998, BLOOD, V91, P3862
  • [9] ALLEN D, 1980, BIOCHEM J, V188, P881
  • [10] Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure
    Amabile, N
    Guérin, AP
    Leroyer, A
    Mallat, Z
    Nguyen, C
    Boddaert, J
    London, GM
    Tedgui, A
    Boulanger, CM
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (11): : 3381 - 3388